Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CES2 | O00748 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL8828343 | 0.97 | ALDH1A1 (0.39) | ALDH1A1TP53TSHRCA2CES2 | |
| Trichloromonofluoromethane SCHEMBL11804529 | 0.81 | ALDH1A1 (0.44) | ALDH1A1TP53TSHRCA2 | |
| SCHEMBL3732763 | 0.81 | CA2 (0.39) | ALDH1A1TP53TSHRCA2CES2 | |
| SCHEMBL4209214 | 0.79 | ALDH1A1 (0.33) | ALDH1A1TP53TSHRCA2CES2 | |
| SCHEMBL5861894 | 0.79 | ALDH1A1 (0.41) | ALDH1A1TP53TSHRCA2 | |
| SCHEMBL7633721 | 0.79 | ALDH1A1 (0.41) | ALDH1A1TP53TSHRCA2 | |
| SCHEMBL4184754 | 0.79 | ALDH1A1 (0.33) | ALDH1A1TP53TSHRCA2CES2 | |
| Trifluoroacetic Acid SCHEMBL4318055 | 0.78 | ALDH1A1 (0.50) | ALDH1A1TP53TSHRCA2 | |
| SCHEMBL344 | 0.76 | CA2 (0.41) | ALDH1A1CA2CES2 | |
| SCHEMBL27892503 | 0.76 | CA2 (0.41) | ALDH1A1CA2CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115043794-A | Preparation method of allyl fluorine-containing glycidyl ether | 杭州宝明新材料科技有限公司 | 2022-09-13 | — | — | CN | claimed |
| EP-1127865-B1 | Process for producing 1,1,1-Trifluoroacetone | CENTRAL GLASS CO LTD (JP) | 2005-11-02 | — | — | EP | claimed |
| US-6340776-B2 | HYROGENOLYSIS OF HALOGENATED TRIFLUOROACETONE BY HYDROGEN GAS IN PRESENCE OF TRANSITION METAL CATALYST | CENTRAL GLASS COMPANY, LIMITED (JP) | 2002-01-22 | — | — | US | claimed |
| US-20010037041-A1 | Process for producing 1,1,1,-trifluoroacetone | CENTRAL GLASS COMPANY, LIMITED (JP) | 2001-11-01 | — | — | US | claimed |
| EP-1127865-A1 | Process for producing 1,1,1-Trifluoroacetone | Central Glass Company, Limited (JP) | 2001-08-29 | — | — | EP | claimed |
| EP-0872468-B1 | Method for producing 3,3-dichloro-1,1,1-trifluoroacetone | CENTRAL GLASS CO LTD (JP) | 2001-07-25 | — | — | EP | claimed |
| US-5905174-A | FLUORINATING PENTACHLOROACETONE WITH HYDROGEN FLUORIDE IN THE PRESENCE OF A CATALYST | CENTRAL GLASS COMPANY, LIMITED (JP) | 1999-05-18 | — | — | US | claimed |
| EP-0872468-A1 | Method for producing 3,3-dichloro-1,1,1-trifluoroacetone | Central Glass Company, Limited (JP) | 1998-10-21 | — | — | EP | claimed |
| US-4393183-A | STORAGE STABILITY, BONDING STRENGTH | TOAGOSEI CHEMICAL INDUSTRY CO., LTD. (JP) | 1983-07-12 | — | — | US | claimed |
| US-4059610-A | Process for preparing isocyanic acid derivatives | KAO SOAP CO., LTD. (JA) | 1977-11-22 | — | — | US | claimed |
| JP-10330308-A | — | — | None | — | — | JP | disclosed |
| CN-115043794-A | Preparation method of allyl fluorine-containing glycidyl ether | 杭州宝明新材料科技有限公司 | 2022-09-13 | — | — | CN | disclosed |
| CN-114685822-A | Non-fibrous membrane and cell layer sheet | 财团法人工业技术研究院 | 2022-07-01 | — | — | CN | disclosed |
| CN-109942393-B | Preparation method of 1,1, 1-trifluoroacetone | 赵博佑 | 2021-11-19 | — | — | CN | disclosed |
| CN-112745194-A | Process for continuously producing hexafluoroisopropanol by using hexafluoropropylene oxide as raw material | 山东华夏神舟新材料有限公司 | 2021-05-04 | — | — | CN | disclosed |
| US-4016146-A | Phenethylamine antigenic conjugates, their preparation, antibodies, and use | BIOLOGICAL DEVELOPMENTS, INC. (US) | 1977-04-05 | — | — | US | disclosed |
| US-3996344-A | Phenethylamine antigenic conjugates, their preparation, antibodies and use | BIOLOGICAL DEVELOPMENTS, INC. (US) | 1976-12-07 | — | — | US | disclosed |
| US-3996376-A | Halogenated dioxolane tranquilizers | ICI UNITED STATES INC. (US) | 1976-12-07 | — | — | US | disclosed |
| US-3993632-A | PROPELLANT BINDER | SHELL OIL COMPANY (US) | 1976-11-23 | — | — | US | disclosed |
| US-3962171-A | COMPOSITION FOR PROTECTING SURFACES | MCGARRY & WATERS (US) | 1976-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010037041-A1 | Process for producing 1,1,1,-trifluoroacetone | TALDO1, HVCN1, TPO | ALDH1A1 1200/4885TP53 3716/4885TSHR 207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.